Developing a new device to monitor heart failure treatment remotely
Official title: Initial Animal Validation of a Multimodal Molecular Monitor for Heart Failure Treatment
Funded at Kilele Health INC. · NIH-11072993 · Data updated 2026-11-12
This study is testing a new device that can continuously check important health markers in heart failure patients after they leave the hospital, so they can be monitored from home and avoid frequent trips to the doctor.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kilele Health INC. NIH-funded |
| Lab location | 1 site (Oakwood, United States) |
| Project start | May 1, 2024 |
| Project end | July 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $70,623 |
| NIH project number | 5R43HL174179-02 |
| Project ID | NIH-11072993 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients recently diagnosed with heart failure who are in the post-discharge phase.
✕Less likely to help
Patients with stable heart failure who are not recently discharged may not benefit from this research.
What this research studies
This research focuses on creating a continuous molecular monitor that can track important biomarkers like NT-proBNP and potassium in heart failure patients. The goal is to enable remote monitoring during the critical 30-90 days after hospital discharge, reducing the need for frequent outpatient visits. By leveraging technology, this approach aims to improve treatment outcomes and patient management in a more decentralized care setting. The research is based on findings from the STRONG-HF trial, which highlighted the importance of these biomarkers in managing heart failure effectively.
Why it matters
Potential benefit: If successful, this research could lead to better management of heart failure, reducing hospital readmissions and improving patient outcomes.
How similar studies have gone: Previous studies have shown success in remote monitoring for chronic conditions, indicating a promising avenue for this novel approach in heart failure management.
Where this research is happening
-
Kilele Health INC.
Oakwood, United States Active
Researchers
- Principal investigator: Schreiber, Sven — Kilele Health INC.
- Study coordinator: Schreiber, Sven
Related research
Other NIH-funded projects on the same topics.
-
AI-supported heart failure diagnosis and management in Rwanda
Aiming to help people with suspected heart failure in Rwanda get faster, more accurate diagnoses and better care using AI-guided ultrasound and care protocols.
-
AI-assisted heart failure diagnosis in Rwanda using focused ultrasound
An NIH-funded project will test whether AI-enhanced, easy-to-use heart ultrasound can help non-experts diagnose and manage heart failure in Rwanda.
-
HF endotypes in heart failure using ethical multi-modal AI and molecular data
A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.
-
Triple gene therapy approach to heal the heart after a heart attack
A new therapy combines three genetic approaches delivered by a virus to help the heart heal after a heart attack.
-
Digital-first heart failure care delivery in Uganda
A targeted program in Uganda tests a digital care plan to help people with heart failure manage their symptoms at home.
-
Digital-first heart failure care delivery in Uganda
A study to test digital self-care tools to help people with heart failure in Uganda manage symptoms and stay healthier.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.